With post-pandemic Medicaid enrollments on the decline and expected to fall further, revenue cycle leaders warn that ...

Hospitals affiliated with Mount Sinai, the University of Michigan and the University of Kansas allege that CVS artificially ...

When hospitals overcharge insurers for drugs they bought at deep 340B discounts, taxpayers, employers, and insured patients ...

Dan Crippen was the director of the Congressional Budget Office from 1999 to 2003. In its first report on the 340B drug discount program's effect on the budget, the Congressional Budget Office ...

Effective compliance now spans transaction eligibility, OPAIS synchronization, Medicaid exclusion validation, cost-report ...

Three health systems are suing CVS Health, alleging the company and its pharmacy subsidiaries diverted roughly $250 million in savings from the 340B Drug Pricing Program. The 340B program was ...

Drug manufacturers participating in the Section 340B Drug Pricing Program now face a significant new litigation risk under the False Claims Act (“FCA”). In a recent decision, Adventist Health System v ...

Minnesota's 340B drug discount program faces scrutiny as small clinics struggle and large hospitals profit, sparking ...

Pending legislation to expand providers’ access to discounted drugs has sparked strong lobbying campaigns for and against the proposal.

Nevada hospitals want stronger protections for a federal drug discount program that helps patients access lower-cost prescriptions.